XTL Biopharmaceuticals Ltd ADR (XTLB) — Net Asset Momentum
XTL Biopharmaceuticals Ltd ADR (XTLB) recorded a net asset momentum of 144.8% as of December 2024, with net assets of $5.43 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See XTL Biopharmaceuticals Ltd ADR (XTLB) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
XTL Biopharmaceuticals Ltd ADR Net Asset Momentum (2002–2024)
This chart tracks XTL Biopharmaceuticals Ltd ADR's year-over-year net asset growth across 23 annual reporting periods from 2002 to 2024. The most recent momentum reading is +144.8%, with net assets of $5.43 Million USD as of December 2024. Read XTL Biopharmaceuticals Ltd ADR total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for XTL Biopharmaceuticals Ltd ADR (2002–2024)
The table below shows the complete annual net asset history for XTL Biopharmaceuticals Ltd ADR from 2002 to 2024, covering 23 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see XTL Biopharmaceuticals Ltd ADR (XTLB) market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $5.43 Million | $8.55 Million | $3.12 Million | ▲ +144.8% |
| 2023 | $2.22 Million | $2.43 Million | $206.00K | ▼ -44.5% |
| 2022 | $4.00 Million | $4.19 Million | $187.00K | ▼ -25.0% |
| 2021 | $5.33 Million | $6.62 Million | $1.28 Million | ▼ -14.7% |
| 2020 | $6.25 Million | $6.50 Million | $254.00K | ▼ -10.5% |
| 2019 | $6.98 Million | $7.21 Million | $232.00K | ▼ -16.1% |
| 2018 | $8.32 Million | $8.57 Million | $253.00K | ▲ +130.0% |
| 2017 | $3.62 Million | $6.59 Million | $2.97 Million | ▲ +34.7% |
| 2016 | $2.69 Million | $3.02 Million | $330.00K | ▼ -45.0% |
| 2015 | $4.89 Million | $5.32 Million | $436.00K | ▲ +4.4% |
| 2014 | $4.68 Million | $5.64 Million | $965.00K | ▼ -31.0% |
| 2013 | $6.79 Million | $8.02 Million | $1.23 Million | ▼ -28.0% |
| 2012 | $9.42 Million | $11.09 Million | $1.66 Million | ▲ +173.6% |
| 2011 | $3.44 Million | $4.07 Million | $629.00K | ▲ +21.5% |
| 2010 | $2.83 Million | $3.80 Million | $963.00K | ▲ +40385.7% |
| 2009 | $7.00K | $715.00K | $708.00K | ▼ -99.5% |
| 2008 | $1.43 Million | $3.43 Million | $2.00 Million | ▼ -83.3% |
| 2007 | $8.56 Million | $14.13 Million | $5.56 Million | ▼ -62.4% |
| 2006 | $22.76 Million | $26.90 Million | $4.14 Million | ▲ +102.3% |
| 2005 | $11.25 Million | $15.15 Million | $3.90 Million | ▼ -42.6% |
| 2004 | $19.60 Million | $25.62 Million | $6.02 Million | ▼ -4.9% |
| 2003 | $20.61 Million | $24.85 Million | $4.25 Million | ▼ -40.8% |
| 2002 | $34.83 Million | $38.42 Million | $3.59 Million | — |